367 related articles for article (PubMed ID: 30470876)
1. Anti-VEGF treatment for choroidal neovascularization complicating pattern dystrophy-like deposit associated with pseudoxanthoma elasticum.
Battaglia Parodi M; Romano F; Marchese A; Arrigo A; Llorenç V; Cicinelli MV; Bandello F; Adán A
Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):273-278. PubMed ID: 30470876
[TBL] [Abstract][Full Text] [Related]
2. Aflibercept for choroidal neovascularizations secondary to pseudoxanthoma elasticum: a prospective study.
Gliem M; Birtel J; Herrmann P; Fimmers R; Berger M; Coch C; Wingen A; Holz FG; Charbel Issa P
Graefes Arch Clin Exp Ophthalmol; 2020 Feb; 258(2):311-318. PubMed ID: 31863395
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal Bevacizumab for Nonsubfoveal Choroidal Neovascularization Associated With Angioid Streaks: 3-Year Follow-up Study.
Iacono P; Battaglia Parodi M; La Spina C; Bandello F
Am J Ophthalmol; 2016 May; 165():174-8. PubMed ID: 27013066
[TBL] [Abstract][Full Text] [Related]
4. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F
Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235
[TBL] [Abstract][Full Text] [Related]
5. Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum.
Finger RP; Charbel Issa P; Schmitz-Valckenberg S; Holz FG; Scholl HN
Retina; 2011; 31(7):1268-78. PubMed ID: 21386758
[TBL] [Abstract][Full Text] [Related]
6. One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation.
Singh SR; Fung AT; Fraser-Bell S; Lupidi M; Mohan S; Gabrielle PH; Zur D; Iglicki M; M López-Corell P; Gallego-Pinazo R; Farinha C; Lima LH; Mansour AM; Casella AM; Wu L; Silva R; Uwaydat SH; Govindahari V; Arevalo JF; Chhablani J
Br J Ophthalmol; 2020 May; 104(5):678-683. PubMed ID: 31401554
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab for choroidal neovascularisation associated with pseudoxanthoma elasticum.
Finger RP; Charbel Issa P; Ladewig M; Holz FG; Scholl HP
Br J Ophthalmol; 2008 Apr; 92(4):483-7. PubMed ID: 18369065
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum.
Bhatnagar P; Freund KB; Spaide RF; Klancnik JM; Cooney MJ; Ho I; Fine HF; Yannuzzi LA
Retina; 2007 Sep; 27(7):897-902. PubMed ID: 17891014
[TBL] [Abstract][Full Text] [Related]
9. PSEUDOXANTHOMA ELASTICUM: SUCCESSFUL LONG-TERM MANAGEMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO ANGIOID STREAKS WITH PRO RE NATA INTRAVITREAL BEVACIZUMAB INJECTIONS.
Kim J; Dalziel D
Retin Cases Brief Rep; 2021 May; 15(3):246-250. PubMed ID: 30048402
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab for nonsubfoveal choroidal neovascularization associated with angioid streaks.
Battaglia Parodi M; Iacono P; La Spina C; Berchicci L; Scotti F; Leys A; Introini U; Bandello F
Am J Ophthalmol; 2014 Feb; 157(2):374-377.e2. PubMed ID: 24211865
[TBL] [Abstract][Full Text] [Related]
11. MULTIMODAL IMAGING OF FOCAL CHOROIDAL EXCAVATION COMPLICATED BY CHOROIDAL NEOVASCULARIZATION IN A PATIENT WITH ANGIOID STREAKS AND PSEUDOXANTHOMA ELASTICUM.
Ferreira BFA; Preti RC; Schmidt MB; Zacharias LC; Takahashi WY; Monteiro MLR
Retin Cases Brief Rep; 2021 Mar; 15(2):155-162. PubMed ID: 29965887
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Follow-Up of Choroidal Neovascularization due to Angioid Streaks with pro re nata Intravitreal Anti-VEGF Treatment.
Giacomelli G; Finocchio L; Biagini I; Sodi A; Murro V; Introini U; Varano M; Bandello F; Menchini U
Ophthalmologica; 2017; 238(1-2):44-51. PubMed ID: 28641290
[TBL] [Abstract][Full Text] [Related]
13. Treatment of choroidal neovascularization using intravitreal bevacizumab.
Pedersen R; Soliman W; Lund-Andersen H; Larsen M
Acta Ophthalmol Scand; 2007 Aug; 85(5):526-33. PubMed ID: 17511757
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks: a long-term follow-up study.
Rosina C; Romano M; Cigada M; de Polo L; Staurenghi G; Bottoni F
Eur J Ophthalmol; 2015; 25(1):47-50. PubMed ID: 25044143
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab for choroidal neovascularisation in serpiginous choroiditis.
Parodi MB; Iacono P; La Spina C; Knutsson KA; Mansour A; Arevalo JF; Bandello F
Br J Ophthalmol; 2014 Apr; 98(4):519-22. PubMed ID: 24414400
[TBL] [Abstract][Full Text] [Related]
16. Ranibizumab for choroidal neovascularization secondary to pseudoxanthoma elasticum: 4-year results from the PIXEL study in France.
Mimoun G; Ebran JM; Grenet T; Donati A; Cohen SY; Ponthieux A
Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1651-1660. PubMed ID: 28493086
[TBL] [Abstract][Full Text] [Related]
17. Polypoidal choroidal vasculopathy in a patient with angioid streaks treated by bevacizumab.
Chebil A; Saidane R; Falfoul Y; El Matri K; Choura R; El Matri L
Tunis Med; 2020 Oct; 98(10):754-761. PubMed ID: 33479949
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks: one year of follow-up.
El Matri L; Kort F; Bouraoui R; Karim B; Chebil A; Chaker N
Acta Ophthalmol; 2011 Nov; 89(7):641-6. PubMed ID: 21155980
[TBL] [Abstract][Full Text] [Related]
19. An atypical case of choroidal neovascularization associated with pseudoxanthoma elasticum treated with intravitreal bevacizumab: a case report.
Karampelas M; Soumplis V; Karagiannis D; Parikakis E; Webster AR
BMC Res Notes; 2013 Dec; 6():530. PubMed ID: 24325973
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum.
Myung JS; Bhatnagar P; Spaide RF; Klancnik JM; Cooney MJ; Yannuzzi LA; Freund KB
Retina; 2010 May; 30(5):748-55. PubMed ID: 19996818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
